Since 1926 when Lewis and Drury investigated the pharmacological aspects of quini-,ine, there have been many reports on its toxic manifestations. Scientific investigation of toxicity has, of necessity, been carried out on animals. Luchi, Helwig, and Conn (I963) ,studied the toxic effects on the hearts of dogs. Cardiac toxicity in humans is usually reported as a clinical side effect during quinidine {therapy. We report a case of oral quinidine overdose as a suicide attempt in a patient with no previous history of cardiovascular or neurological disease.
Case report "The patient, a 57-year-old woman, ingested 20 200 mg quinidine tablets. When seen ij hours later at a Central Receiving Hospital, she was ataxic and lethargic. Vomiting was induced at that time, but no tablet residue was obtained. She was then transferred to the Los Angeles County-University of Southern California Medical Center. On arrival on the admitting ward, 3 'hours after ingestion of the tablets, she had a grand mal convulsion which recurred three times in the following 3 hours. The chest x-ray was normal.
Therapy and progress The patient was given a goo ml infusion of i/6 molar lactate which had no effect on the blood pressure or the electrocardiogram. The blood pressure began to rise with an intravenous infusion of metaraminol (ioo mg in i litre 5% dextrose and water); 88 mEq sodium bicarbonate was administered intravenously and followed by 45 mEq potassium chloride as a slow infusion in i litre of 5 per cent dextrose and water. After initiation of therapy, the central venous pressure was found to be I8 cm water. Urine output in the first 3 hours was negligible but improved after the intravenous administration of 20 mg frusemide. Forty-eight hours after ingestion (C) the electrocardiogram had almost returned to normal. There was some residual notching of the P waves in the praecordial leads. The RSR' of the right praecordial leads was retained from the admission tracing and the QT interval was slightly prolonged.
Pacing thresholds At the onset, we were unable to obtain a pacing threshold with 22 mA, whereas some 36 hours after admission, pacing was achieved with 3X5 mA.
Discussion
An interesting spectrum of cardiovascular and neurological side effects from a large oral dose of quinidine was observed in a previously healthy patient.
The cardiac toxicity is specifically of interest since it occurred in a normal heart. The rapid development of conduction defects and hypotension have been previously observed but usually in association with a variety of arrhythmias (Finnegan and Trounce, 1954; Selzer and Wray, 1964; Seaton, 1966 Thomson (1956) 
